Telomere capture in hepatitis C infection

Cancer Genetics and Cytogenetics

Volumn 191, Issue 2, 2009, Pages 63-66

  Goldberg Bittman, Lilach ^a,b   Amiel, Aliza ^a,b   Hadary, Ruth ^a,c   Fejgin, Moshe D ^a,c   Quitt, Miriam ^d   Kitay Cohen, Yona ^a,c  

^a MEIR MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d Carmel Hospital   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; HEPATITIS C; HUMAN; MOLECULAR PROBE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TELOMERE;

CELL CULTURE TECHNIQUES; CHROMOSOMAL INSTABILITY; CHROMOSOMES, HUMAN; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOCYTES; LYMPHOMA, NON-HODGKIN; RECOMBINATION, GENETIC; REFERENCE VALUES; TELOMERE; TRANSLOCATION, GENETIC;

HEPATITIS C VIRUS;

EID: 65549142163     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.01.013     Document Type: Article

References (24)

1. Muller H.J. The remaking of chromosomes. Collecting Net 13 (1938) 181-198
2. McClintock B. The stability of broken ends of chromosomes in zea mays. Genetics (1941) 234-282
3. Meltzer P.S., Guan X., and Trent J.M. Telomere capture stabilizes chromosome breakage. Nat Genet (1993) 252-255
4. Preston R.J. Telomeres, telomerase and chromosome stability. Rad Res 147 (1997) 529-534
5. Greider C.W. In: Blackburn E.H., and Greider C.W. (Eds). Telomerase biochemistry and regulation in telomeres (1995), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 35-68
6. Lingner H.T.R., Shevchenko A., Mann M., Lundblad V., and Cech T.R. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276 (1997) 561-567
7. Melek M., and Shippen D.E. Chromosome healing. Spontaneous and programmed de novo telomere formation by telomerase. Bio Essays 18 (1996) 301-308
8. Amiel A., Goldzak G., Gaber E., Yosef G., Fejgin M.D., Yukla M., and Lishner M. Random aneuploidy and telomere capture in chronic lymphocytic leukemia and chronic myeloid leukemia patients. Cancer Genet Cytogenet 163 (2005) 12-16
9. Chabchoub E., Rodriguez L., Galan E., Mansilla E., Martínez-Fernandez M.L., Martínez-Frías M.L., Fryns J.P., and Vermeesch J.R. Molecular characterization of a mosaicism with a complex chromosome rearrangement. Evidence for coincident chromosome healing by telomere capture and neo-telomere formation. J Med Genet 44 (2007) 250-256
10. Monteverde A., Rivano M.T., Allegra G.C., Monteverde A.I., Zigrossi P., Baglioni P., Gobbi M., Falini B., Bordin G., and Pileri S. Essential mixed cryoblobulinemia type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections. Acta Haematol 79 (1988) 20-25
11. Coleman W.B. Mechanisms of human hepatocarcinogenesis. Curr Mol Med 3 (2003) 573-588
12. Sekoguchi S., Nakajima T., Moriguchi M., Jo M., Nishikawa T., Katagishi T., Kimura H., Minami M., Itoh Y., Kagawa K., Tani Y., and Okanoue T. Role of cell-cycle turnover and oxidative stress in telomere shortening and cellular senescence in patients with chronic hepatitis. CJ Gastroenterol Hepatol 22 (2007) 182-190
13. Amiel A, Fejgin MD, Goldberg-Bittman L, Sharoni R, Hadary R, Kitay-Cohen Y. Telomere aggregates in hepatitis C patients. Cancer Invest (in press).
14. Goldberg-Bittman L., Kitay-Cohen Y., Hadari R., Yukla M., Fejgin M.D., and Amiel A. Random aneuploidy in chronic hepatitis C patients. Cancer Genet Cytogenet 108 (2008) 20-23
15. Brown W.R.A., MacKinnon P.J., Villasante A., Spurr N., Buckle V.J., and Dobson M.J. Structure and polymorphism of human telomere-associated DNA. Cell 63 (1990) 119-132
16. Kitay-Cohen Y., Goldberg-Bittman L., Quitt M., Hadary R., Fejgin M.D., Yukla M., and Amiel A. Telomere length in hepatitis C. Cancer Genet Cytogenet 187 (2008) 34-38
17. Satra M., Dalekos G.N., Kollia P., Vamvakopoulos N., and Tsezou A. Telomerase reverse transcriptase mRNA expression in peripheral lymphocytes of patients with chronic HBV and HCV infections. J Viral Hepatol 12 (2005) 488-493
18. Leach N.T., Rehder C., Jensen K., Holf S., and Jackson-Cook C. Human chromosomes with shorter telomeres and large heterochromatin regions have a higher frequency of acquired somatic cell aneuploidy. Mech Age Develop 125 (2004) 563-573
19. Amiel A., Elis A., Blumenthal D., Gaber E., Fejgin M.D., Dubinsky R., and Lishner M. Modified order of allelic replication in lymphoma patients at different disease stages. Cancer Genet Cytogenet 125 (2001) 156-160
20. Amiel A., Kitay-Cohen Y., Fejgin M.D., and Lishner M. Replication status as a marker for predisposition for lymphoma in patients with chronic hepatitis C with and without cryoglobulinemia. Exp Hematol 28 (2000) 156-160
21. Amiel A., Yukla M., Gaber E., Leopold L., Josef G., Fejgin M., and Lishner M. Random aneuploidy in CML patients at diagnosis and under imatinib treatment. Cancer Genet Cytogenet 168 (2006) 120-123
22. Tokita H., Fukui H., Tanaka A., Kamitsukasa H., Yagura M., Harada H., and Okamoto H. Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy. J Gastoenterol & Hepatol 20 (2005) 752-758
23. Chavalitdhamrong D., and Tanwandee T. Long-term outcomes of chronic hepatitis C patients with sustained virological response at 6 months after the end of treatment. World J Gastroenterol 12 (2006) 5532-5535
24. Tanaka A., Uegaki S., Kurihara H., Aida K., Mikami M., Nagashima I., Shiga J., and Takikawa H. Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C. World J Gastroenterol 13 (2007) 5180-5187